Conference abstractPublished 20 Mar 2019
Ultrasound sensitive nanobubbles containing Paclitaxel, YM155, and siRNA as gene carriers for the therapy of lung cancer
Ege University, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
23% of the worldwide cancer-related death rate is due to lung cancer, more than the sum of breast, colon and prostate cancer. A great deal in common for almost each cancer type, including lung cancer, is an overexpression of the apoptosis inhibitor survivin. For improving the chemotherapy several strategies were performed. Previously, ultrasound sensitive nanobubbles containing paclitaxel, survivin-siRNA and survivin inhibitor sepantronium bromide (YM155), respectively, were developed against A549 lung cancer cells. The paclitaxel-loaded nanobubbles had a particle size of 309nm and a zeta potential of 34mV, the paclitaxel and YM155 loaded nanobubbles had a particle size of 57nm and a ZP of 47mV, while the PTX and siRNA loaded nanobubbles had a particle size of 252nm and a ZP of 27mV. The cytotoxicity studies revealed promising results and encouraged for further investigations. The aim of this study was to evaluate the siRNA complexation, serum stability, gene silencing efficiency, and Apoptosis. The developed nanobubbles were able to form a complex with survivin-siRNA and protected the siRNA from nucleases. The gene silencing efficiency and Apoptosis were evaluated, with and without ultrasound exposure, by qPCR and Apoptosis kits and showed that NB formulations were able to silence survivin expression and induce apoptosis in the A549 cell line. Acknowledgement: This study has been financially supported by TUBITAK under grant code 116S213
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNanotechnology
- SubjectOncology & Cancer
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Yucel Baspinar”